ESSENTIAL FATTY-ACID METABOLISM IN BOYS WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDER

被引:294
作者
STEVENS, LJ
ZENTALL, SS
DECK, JL
ABATE, ML
WATKINS, BA
LIPP, SR
BURGESS, JR
机构
[1] PURDUE UNIV,DEPT FOOD & NUTR,W LAFAYETTE,IN 47907
[2] PURDUE UNIV,DEPT EDUC STUDIES,W LAFAYETTE,IN 47907
[3] PURDUE UNIV,DEPT STAT,W LAFAYETTE,IN 47907
[4] PURDUE UNIV,DEPT FOOD SCI,W LAFAYETTE,IN 47907
[5] ARNETT CLIN,LAFAYETTE,IN
关键词
ESSENTIAL FATTY ACIDS (EFAS); ATTENTION-DEFICIT HYPERACTIVITY DISORDER (ADHD); THIRST; DRY SKIN; FREQUENT URINATION; ARACHIDONIC ACID (20/4N-6); DOCOSAHEXAENOIC ACID (22/6N-3);
D O I
10.1093/ajcn/62.4.761
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Attention-deficit hyperactivity disorder (ADHD) is the term used to describe children who are inattentive, impulsive, and hyperactive. The cause is unknown and is thought to be multifactorial. Based on the work of others, we hypothesized that some children with ADHD have altered fatty acid metabolism. The present study found that 53 subjects with ADHD had significantly lower concentrations of key fatty acids in the plasma polar lipids (20:4n-6; 20:5n-3, and 22:6n-3) and in red blood cell total lipids (20:4n-6 and 22:4n-6) than did the 43 control subjects. Also, a subgroup of 21 subjects with ADHD exhibiting many symptoms of essential fatty acid (EFA) deficiency had significantly lower plasma concentrations of 20:4n-6 and 22:6n-3 than did 32 subjects with ADHD with few EFA-deficiency symptoms. The data are discussed with respect to cause, but the precise reason for lower fatty acid concentrations in some children with ADHD is not clear.
引用
收藏
页码:761 / 768
页数:8
相关论文
共 47 条
[1]  
AHMANN PA, 1993, PEDIATRICS, V91, P1101
[2]   THE EFFECTS OF ESSENTIAL FATTY-ACID SUPPLEMENTATION BY EFAMOL IN HYPERACTIVE-CHILDREN [J].
AMAN, MG ;
MITCHELL, EA ;
TURBOTT, SH .
JOURNAL OF ABNORMAL CHILD PSYCHOLOGY, 1987, 15 (01) :75-90
[3]  
[Anonymous], 1989, SAS STAT USERS GUIDE, V2
[4]   GAMMA-LINOLENIC ACID FOR ATTENTION-DEFICIT HYPERACTIVITY DISORDER - PLACEBO-CONTROLLED COMPARISON TO D-AMPHETAMINE [J].
ARNOLD, LE ;
KLEYKAMP, D ;
VOTOLATO, NA ;
TAYLOR, WA ;
KONTRAS, SB ;
TOBIN, K .
BIOLOGICAL PSYCHIATRY, 1989, 25 (02) :222-228
[5]  
BAKER SM, 1985, J LEARN DISABIL, V8, P581
[6]  
Barkley R.A., 1998, ATTENTION DEFICIT HY
[7]   COMPREHENSIVE EVALUATION OF ATTENTION-DEFICIT DISORDER WITH AND WITHOUT HYPERACTIVITY AS DEFINED BY RESEARCH CRITERIA [J].
BARKLEY, RA ;
DUPAUL, GJ ;
MCMURRAY, MB .
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1990, 58 (06) :775-789
[8]  
BHAT KS, 1967, AM J CLIN NUTR, V20, P236
[9]  
BJERVE KS, 1991, HLTH EFFECTS OMEGA 3, P133
[10]  
BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911